Daxor Corp (DXR)
9.284
+0.35
(+3.97%)
USD |
NASDAQ |
Nov 22, 16:00
9.07
-0.21
(-2.31%)
Pre-Market: 20:00
Daxor Revenue (Annual): 1.280M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 1.280M |
December 31, 2022 | 6.310M |
December 31, 2021 | 5.821M |
December 31, 2020 | -0.9963M |
December 31, 2019 | -0.115M |
December 31, 2018 | -0.9184M |
December 31, 2017 | -1.012M |
December 31, 2016 | 1.835M |
December 31, 2015 | -7.444M |
December 31, 2014 | -4.054M |
December 31, 2013 | -11.56M |
December 31, 2011 | 1.277M |
December 31, 2010 | 1.518M |
December 31, 2009 | 1.689M |
December 31, 2008 | 1.761M |
December 31, 2007 | 1.870M |
December 31, 2006 | 1.486M |
December 31, 2005 | 1.344M |
December 31, 2004 | 1.066M |
December 31, 2003 | 1.014M |
Date | Value |
---|---|
December 31, 2002 | 0.7676M |
December 31, 2001 | 0.7584M |
December 31, 2000 | 0.7458M |
December 31, 1999 | 0.5754M |
December 31, 1998 | 0.30M |
December 31, 1997 | 0.5297M |
December 31, 1996 | 2.90M |
December 31, 1995 | 4.70M |
December 31, 1994 | 4.60M |
December 31, 1993 | 4.80M |
December 31, 1992 | 6.10M |
December 31, 1991 | 3.90M |
December 31, 1990 | 4.60M |
December 31, 1989 | 2.20M |
December 31, 1988 | 4.40M |
December 31, 1987 | 1.90M |
December 31, 1986 | 1.80M |
December 31, 1985 | 1.80M |
December 31, 1984 | 1.80M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
-0.9963M
Minimum
2020
6.310M
Maximum
2022
2.460M
Average
1.280M
Median
2023
Revenue (Annual) Benchmarks
AptarGroup Inc | 3.487B |
Sanara MedTech Inc | 64.99M |
Precision Optics Corp Inc | 19.10M |
Warby Parker Inc | 669.76M |
Perspective Therapeutics Inc | -- |